ESC Premium Access

Bleeding risk as one of major hurdles in stroke prevention therapy prescription.


Congress Presentation

About the speaker

Professor Christopher B Granger

Duke University Medical Center, Durham (United States of America)
15 presentations
1 follower

2 more presentations in this session

Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)


How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?

Speaker: Professor P. Kamphuisen (Hilversum, NL)


Access the full session

Biomarker-based approaches for improved atrial fibrillation management

Speakers: Professor C. Granger, Associate Professor Z. Hijazi, Professor P. Kamphuisen

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb